SIRT1 and metabolic dysfunction-associated steatotic liver disease: MiR-34a, inhibiting SIRT-1, leads to the increment of p53 acetylation and transcription conducting to expression of pro-apoptotic genes and then apoptosis suggesting miR-34a as a possible regulator of hepatocytes apoptosis during NAFLD.